The Route of Leishmania tropica Infection Determines Disease Outcome and Protection against Leishmania major in BALB/c Mice
Hamid Mahmoudzadeh-Niknam, Ghader Khalili, Firoozeh Abrishami, Ali Najafy, Vahid Khaze
Korean J Parasito. 2013;51(1):69-74.   Published online 2013 Feb 18     DOI: https://doi.org/10.3347/kjp.2013.51.1.69
Citations to this article as recorded by Crossref logo
Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against Leishmania mexicana Infection
Bernard Ong’ondo Osero, Zama Cele, Raphael Taiwo Aruleba, Rebeng A. Maine, Mumin Ozturk, Manfred B. Lutz, Frank Brombacher, Ramona Hurdayal
Frontiers in Immunology.2022;[Epub]     CrossRef
A Mouse Model of Ulcerative Cutaneous Leishmaniasis by Leishmania (Viannia) panamensis to Investigate Infection, Pathogenesis, Immunity, and Therapeutics
Natalia Muñoz-Durango, Alexander Gómez, Natalia García-Valencia, Miguel Roldán, Marcela Ochoa, David E. Bautista-Erazo, José R. Ramírez-Pineda
Frontiers in Microbiology.2022;[Epub]     CrossRef
The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica
Shima Nahidi, Elham Gholami, Yasaman Taslimi, Sima Habibzadeh, Negar Seyed, Elaheh Davarpanah, Alireza Ghanadan, Sima Rafati, Tahereh Taheri
Parasite Immunology.2020;[Epub]     CrossRef
To the Skin and Beyond: The Immune Response to African Trypanosomes as They Enter and Exit the Vertebrate Host
Omar A. Alfituri, Juan F. Quintana, Annette MacLeod, Paul Garside, Robert A. Benson, James M. Brewer, Neil A. Mabbott, Liam J. Morrison, Paul Capewell
Frontiers in Immunology.2020;[Epub]     CrossRef
DermotropicLeishmania donovaniin Sri Lanka: visceralizing potential in clinical and preclinical studies
K. K. G. D. U. L. KARIYAWASAM, A. SELVAPANDIYAN, H. V. Y. D. SIRIWARDANA, A. DUBE, P. KARUNANAYAKE, S. A. S. C. SENANAYAKE, R. DEY, S. GANNAVARAM, H. L. NAKHASI, N. D. KARUNAWEERA
Parasitology.2018; 145(4): 443.     CrossRef
Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice
Mosayeb Rostamian, Fariborz Bahrami, Hamid M. Niknam, Humberto Lanz-Mendoza
PLOS ONE.2018; 13(9): e0204491.     CrossRef
Route of Infection Affects Pathogenicity of Leishmania major in BALB/c Mice
Ehsan Sarreshteh, Mosayeb Rostamian, Mahsa Tat Asadi, Firoozeh Abrishami, Ali Najafi, Maryam Abolghazi, Hamid Mahmoudzadeh Niknam
Journal of Medical Microbiology and Infectious Diseases .2017; 5(1): 26.     CrossRef
Indigenous microbiota and Leishmaniasis
M. E. M. Lopes, M. B. H. Carneiro, L. M. dos Santos, L. Q. Vieira
Parasite Immunology.2016; 38(1): 37.     CrossRef
Cross‐protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis
V. T. Martins, D. P. Lage, M. C. Duarte, L. E. Costa, M. A. Chávez‐Fumagalli, B. M. Roatt, D. Menezes‐Souza, C. A. P. Tavares, E. A. F. Coelho
Parasite Immunology.2016; 38(2): 108.     CrossRef
Coinjection with TLR2 Agonist Pam3CSK4 Reduces the Pathology of Leishmanization in Mice
Lu Huang, Meleana Hinchman, Susana Mendez, Mary Ann McDowell
PLOS Neglected Tropical Diseases.2015; 9(3): e0003546.     CrossRef
Site-Dependent Recruitment of Inflammatory Cells Determines the Effective Dose of Leishmania major
Flavia L. Ribeiro-Gomes, Eric Henrique Roma, Matheus B. H. Carneiro, Nicole A. Doria, David L. Sacks, Nathan C. Peters, J. A. Appleton
Infection and Immunity.2014; 82(7): 2713.     CrossRef